Women’s health bill
Executive Summary
Senate Health Committee passes "Women's Health Improvement Act" (S 2328) by voice vote Sept. 5. Bill includes amended version of Sen. Tom Harkin's (D-Iowa) pregnancy legislation, which would have directed FDA to enhance pregnancy drug labeling and would have given the agency authority to require postmarketing studies in pregnant women (1"The Pink Sheet" July 29, p. 11). No drug-related language is included in the final bill...
You may also be interested in...
Pediatric Exclusivity Expansion Floated On Hill; Mandatory Study Bill Pending
An additional three months of exclusivity would be awarded for a company's second round of pediatric studies under a proposed amendment to Sen. Hillary Rodham Clinton's (D-N.Y.) bill to codify FDA's mandatory pediatric study rule
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.